Beech Nut Baby Food Recall Issued Over Glass Contamination Fears

Following report of at least one injury, nearly 2,000 pounds of Beech-Nut baby food have been recalled due to a risk that it may contain small pieces of glass. 

A Beech-Nut sweet potato & chicken recall was announced by the Food Safety and Inspection Service (FSIS) on April 14, after the manufacturer received a complaint involving an oral injury resulting from a fragment of glass in one of the bottles of baby food.

According to a Beech-Nut press release, there is no evidence any other jar has been affected, but the company issued the recall out of an abundance of caution.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Glass fragments in the baby food could cause infants to suffer lacerations to the mouth and lips, or could cause internal injuries or choking if swallowed.

The recall affects 1,920 pounds of “Stage 2 Beech-Nut CLASSICS sweet potato & chicken” sold in four-ounce glass jars. The affected bottles have establishment number P-68A inside the USDA mark of inspection, have an expiration date of “DEC 2016” and includes product numbers “12395750815” through “12395750821”.No other flavors, production dates, or sizes are affected.

The recalled baby food was sold nationwide.

Beech-Nut is encouraging customers to return the recalled baby food to the place of purchase for a full refund or exchange. Consumers can also call the company at (866) 674-4446 to receive a full refund as well.

Anyone who believes their baby has eaten the recalled baby food should contact their medical professional.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.
Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation.